Altered phosphorylated signal transducer and activator of transcription profile of CD4+CD161+ T cells in asthma: Modulation by allergic status and oral corticosteroids

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 6, 2007, Pages 1441-1448

  Gernez, Yael ^a   Tirouvanziam, Rabindra ^a   Nguyen, Khoa D ^a   Herzenberg, Leonard A ^a   Krensky, Alan M ^b   Nadeau, Kari C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Allergy; atopy; fluorescence activated cell sorting; immune polarization

Indexed keywords

BIOLOGICAL MARKER; CD161 ANTIGEN; CORTICOSTEROID; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN;

ALLERGIC ASTHMA; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; EFFECTOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEMORY CELL; MODULATION; PATHOLOGY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; ANTI-ASTHMATIC AGENTS; ANTIGENS, SURFACE; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION PROFILING; HUMANS; HYPERSENSITIVITY; LECTINS, C-TYPE; PHOSPHORYLATION; STAT TRANSCRIPTION FACTORS; T-LYMPHOCYTE SUBSETS;

EID: 36749044956     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.08.012     Document Type: Article

References (42)

1. Cohn L., Elias J.A., and Chupp G.L. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 22 (2004) 789-815
2. Umetsu D.T., and Dekruyff R.H. The regulation of allergy and asthma. Immunol Rev 212 (2006) 238-255
3. O'Byrne P.M. Cytokines or their antagonists for the treatment of asthma. Chest 130 (2006) 244-250
4. Bel E.H. Clinical phenotypes of asthma. Curr Opin Pulm Med 10 (2004) 44-50
5. Buhl R. Anti-IgE antibodies for the treatment of asthma. Curr Opin Pulm Med 11 (2005) 27-34
6. Chatila T.A. Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol Med 10 (2004) 493-499
7. Kaplan M.H., Schindler U., Smiley S.T., and Grusby M.J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4 (1996) 313-319
8. Shimoda K., van Deursen J., Sangster M.Y., Sarawar S.R., Carson R.T., Tripp R.A., et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380 (1996) 630-633
9. Christodoulopoulos P., Cameron L., Nakamura Y., Lemiere C., Muro S., Dugas M., et al. TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression. J Allergy Clin Immunol 107 (2001) 586-591
10. Pernis A.B., and Rothman P.B. JAK-STAT signaling in asthma. J Clin Invest 109 (2002) 1279-1283
11. Zimmermann N., Mishra A., King N.E., Fulkerson P.C., Doepker M.P., Nikolaidis N.M., et al. Transcript signatures in experimental asthma: identification of STAT6-dependent and -independent pathways. J Immunol 172 (2004) 1815-1824
12. Ratthe C., Pelletier M., Chiasson S., and Girard D. Molecular mechanisms involved in interleukin-4-induced human neutrophils: expression and regulation of suppressor of cytokine signaling. J Leukoc Biol 81 (2007) 1287-1296
13. Wang I.M., Lin H., Goldman S.J., and Kobayashi M. STAT-1 is activated by IL-4 and IL-13 in multiple cell types. Mol Immunol 41 (2004) 873-884
14. Parrillo J.E., and Fauci A.S. Mechanisms of glucocorticoid action on immune processes. Annu Rev Pharmacol Toxicol 19 (1979) 179-201
15. Barnes P.J., and Adcock I.M. How do corticosteroids work in asthma?. Ann Intern Med 139 (2003) 359-370
16. Shirai T., Inui N., Suda T., and Chida K. Correlation between peripheral blood T-cell profiles and airway inflammation in atopic asthma. J Allergy Clin Immunol 118 (2006) 622-626
17. Miller R.L., Eppinger T.M., McConnell D., Cunningham-Rundles C., and Rothman P. Analysis of cytokine signaling in patients with extrinsic asthma and hyperimmunoglobulin E. J Allergy Clin Immunol 102 (1998) 503-511
18. Perez O.D., and Nolan G.P. Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level. Immunol Rev 210 (2006) 208-228
19. Loza M.J., Metelitsa L.S., and Perussia B. NKT and T cells: coordinate regulation of NK-like phenotype and cytokine production. Eur J Immunol 32 (2002) 3453-3462
20. Iliopoulou E.G., Karamouzis M.V., Missitzis I., Ardavanis A., Sotiriadou N.N., Baxevanis C.N., et al. Increased frequency of CD4+ cells expressing CD161 in cancer patients. Clin Cancer Res 12 (2006) 6901-6909
21. Takahashi T., Dejbakhsh-Jones S., and Strober S. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 176 (2006) 211-216
22. Lanier L.L., Chang C., and Phillips J.H. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 153 (1994) 2417-2428
23. Pozo D., Vales-Gomez M., Mavaddat N., Williamson S.C., Chisholm S.E., and Reyburn H. CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinase. J Immunol 176 (2006) 2397-2406
24. Gulbins E., and Kolesnick R. Raft ceramide in molecular medicine. Oncogene 22 (2003) 7070-7077
25. Ho L.P. Natural killer T cells in asthma-toward increased understanding. N Engl J Med 356 (2007) 1466-1468
26. Chen W., and Khurana Hershey G.K. Signal transducer and activator of transcription signals in allergic disease. J Allergy Clin Immunol 119 (2007) 529-541
27. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136 (1987) 225-244
28. Bousquet J. Global initiative for asthma (GINA) and its objectives. Clin Exp Allergy 30 suppl 1 (2000) 2-5
29. Efthimiou P., Paik P.K., and Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 65 (2006) 564-572
30. Shi H.Z., Li S., Xie Z.F., Qin X.J., Qin X., and Zhong X.N. Regulatory CD4+CD25+ T lymphocytes in peripheral blood from patients with atopic asthma. Clin Immunol 113 (2004) 172-178
31. Baumgarth N., and Roederer M. A practical approach to multicolor flow cytometry for immunophenotyping. J Immunol Methods 243 (2000) 77-97
32. Herzenberg L.A., Tung J., Moore W.A., Herzenberg L.A., and Parks D.R. Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol 7 (2006) 681-685
33. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 (1988) 837-845
34. Wurtz O., Bajenoff M., and Guerder S. IL-4-mediated inhibition of IFN-gamma production by CD4+ T cells proceeds by several developmentally regulated mechanisms. Int Immunol 16 (2004) 501-508
35. Yu C.R., Mahdi R.M., Ebong S., Vistica B.P., Chen J., Guo Y., et al. Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling. J Immunol 173 (2004) 737-746
36. So E.Y., Kim S.H., Park H.H., Cho B.S., and Lee C.E. Corticosteroid inhibits IL-4 signaling through down-regulation of IL-4 receptor and STAT6 activity. FEBS Lett 518 (2002) 53-59
37. Robertson J.M., MacLeod M., Marsden V.S., Kappler J.W., and Marrack P. Not all CD4+ memory T cells are long lived. Immunol Rev 211 (2006) 49-57
38. Chanez P., Wenzel S.E., Anderson G.P., Anto J.M., Bel E.H., Boulet L.P., et al. Severe asthma in adults: what are the important questions?. J Allergy Clin Immunol 119 (2007) 1337-1348
39. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 130 suppl (2006) 65S-72S
40. Adcock I.M., Chung K.F., Caramori G., and Ito K. Kinase inhibitors and airway inflammation. Eur J Pharmacol 533 (2006) 118-132
41. Tirouvanziam R. Neutrophilic inflammation as a major determinant in the progression of cystic fibrosis. Drug News Perspect 19 (2006) 610-614
42. Deykin A. Biomarker-driven care in asthma: are we there?. J Allergy Clin Immunol 118 (2006) 565-568